[{"indications": "Indications\u00a0superficial malignant and pre-malignant\r\nskin lesions; other malignant disease (section 8.1.3) ", "name": "FLUOROURACIL - PHOTODAMAGE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.8 Sunscreens and camouflagers", "13.8.1 Sunscreen preparations", "Photodamage"], "cautions": "Cautions\u00a0avoid contact with eyes and mucous membranes; caution in handling\u2014irritant to tissues", "side-effects": "Side-effects\u00a0local irritation (use a topical corticosteroid\r\nfor severe discomfort associated with inflammatory reactions), photosensitivity,\r\nerythema multiforme", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200023.htm", "doses": ["See under preparations"], "pregnancy": "Pregnancy\u00a0manufacturers advise avoid (teratogenic)"}, {"indications": "Indications\u00a0\n(From 8.1.3 Antimetabolites: British National Formulary)\nFluorouracil is used to treat a number of solid tumours, including gastro-intestinal tract cancers and breast cancer. It is commonly used with folinic acid in advanced colorectal cancer. It may also be used topically for certain malignant and pre-malignant skin lesions. Toxicity is unusual, but may include myelosuppression, mucositis, and rarely a cerebellar syndrome. On prolonged infusion, a desquamative hand\u2013foot syndrome may occur.; pre-malignant and malignant skin lesions (%s\n(From FLUOROURACIL: British National Formulary)\nFLUOROURACIL)", "name": "FLUOROURACIL - ANTIMETABOLITES", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.3 Antimetabolites", "FLUOROURACIL"], "cautions": "Cautions\u00a0see section 8.1 and notes above; caution in handling\u2014irritant to tissues; interactions: Appendix 1 (fluorouracil)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above; also local irritation with topical preparation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4732.htm", "doses": ["By intravenous injection or infusion or by intra-arterial\r\ninfusion, consult product literature"], "pregnancy": "Pregnancy\u00a0avoid (teratogenic); see also Pregnancy and Reproductive\r\nFunction"}, {"indications": "Indications\u00a0superficial malignant and pre-malignant\r\nskin lesions; other malignant disease (section 8.1.3) ", "name": "FLUOROURACIL With salicylic acid", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.8 Sunscreens and camouflagers", "13.8.1 Sunscreen preparations", "Photodamage", "FLUOROURACIL", "With salicylic acid"], "cautions": "Cautions\u00a0avoid contact with eyes and mucous membranes; caution in handling\u2014irritant to tissues", "side-effects": "Side-effects\u00a0local irritation (use a topical corticosteroid\r\nfor severe discomfort associated with inflammatory reactions), photosensitivity,\r\nerythema multiforme", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/217935.htm", "doses": ["See under preparations", "Name[Actikerall\u00ae (Almirall) ] Solution, fluorouracil 0.5%, salicylic\r\nacid 10%, net price 25\u00a0mL = \u00a338.30. \r\n    Label:\r\n    15Excipients  none as listed in section 13.1.3Dose\u00a0low or moderately thick hyperkeratotic actinic keratosis,\r\napply to affected area once daily for up to 12 weeks; max. area of\r\nskin treated at one time, 25\u00a0cm2 (e.g. 5\u00a0cm x 5\u00a0cm)"], "pregnancy": "Pregnancy\u00a0manufacturers advise avoid (teratogenic)"}, {"indications": "Indications\u00a0\n(From 8.1.3 Antimetabolites: British National Formulary)\nFluorouracil is used to treat a number of solid tumours, including gastro-intestinal tract cancers and breast cancer. It is commonly used with folinic acid in advanced colorectal cancer. It may also be used topically for certain malignant and pre-malignant skin lesions. Toxicity is unusual, but may include myelosuppression, mucositis, and rarely a cerebellar syndrome. On prolonged infusion, a desquamative hand\u2013foot syndrome may occur.; pre-malignant and malignant skin lesions (%s\n(From FLUOROURACIL: British National Formulary)\nFLUOROURACIL)", "name": "FLUOROURACIL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.3 Antimetabolites", "FLUOROURACIL"], "cautions": "Cautions\u00a0see section 8.1 and notes above; caution in handling\u2014irritant to tissues; interactions: Appendix 1 (fluorouracil)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above; also local irritation with topical preparation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4732.htm", "doses": ["By intravenous injection or infusion or by intra-arterial\r\ninfusion, consult product literature"], "pregnancy": "Pregnancy\u00a0avoid (teratogenic); see also Pregnancy and Reproductive\r\nFunction"}]